Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

DAE HWA Pharmaceutical Co., Ltd. (067080.KQ)

Compare
14,180.00
-1,070.00
(-7.02%)
At close: April 4 at 3:30:24 PM GMT+9
Loading Chart for 067080.KQ
  • Previous Close 15,250.00
  • Open 14,770.00
  • Bid 14,010.00 x --
  • Ask 14,050.00 x --
  • Day's Range 13,840.00 - 14,855.00
  • 52 Week Range 8,290.00 - 24,150.00
  • Volume 654,421
  • Avg. Volume 1,681,309
  • Market Cap (intraday) 248.385B
  • Beta (5Y Monthly) 0.07
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 14, 2025 - May 19, 2025
  • Forward Dividend & Yield 100.00 (0.71%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est --

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, urinary incontinence, prostatic hyperplasia, pregnancy, bug bite, anthelmintics, and cosmetic care, as well as vitamins and minerals, tonics, nutrition products. It also provides transdermal drug delivery system, a pharmaceutical preparation that is applied to the intact skin for systemic absorption; and active pharmaceutical ingredients. The company also exports its products to approximately 22 countries, including Asia, South America, the Middle East, and Africa. DAE HWA Pharmaceutical Co., Ltd. was founded in 1984 and is headquartered in Seoul, South Korea.

www.dhpharm.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 067080.KQ

View More

Performance Overview: 067080.KQ

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

067080.KQ
29.62%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

067080.KQ
41.86%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

067080.KQ
69.35%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

067080.KQ
69.58%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 067080.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 067080.KQ

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    248.39B

  • Enterprise Value

    339.80B

  • Trailing P/E

    472.67

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.68

  • Price/Book (mrq)

    3.45

  • Enterprise Value/Revenue

    2.27

  • Enterprise Value/EBITDA

    25.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.33%

  • Return on Assets (ttm)

    2.12%

  • Return on Equity (ttm)

    11.26%

  • Revenue (ttm)

    115.31B

  • Net Income Avi to Common (ttm)

    10.76B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.83B

  • Total Debt/Equity (mrq)

    62.50%

  • Levered Free Cash Flow (ttm)

    -6.4B

Research Analysis: 067080.KQ

View More

Company Insights: 067080.KQ

Research Reports: 067080.KQ

View More

People Also Watch